XML 58 R45.htm IDEA: XBRL DOCUMENT
v3.23.1

Commitments and Contingencies - Additional Information (Detail) - USD ($) |  | 1 Months Ended | 12 Months Ended |  |
--- | --- | --- | --- | --- | ---
Jun. 15, 2022 | Aug. 31, 2022 | Dec. 31, 2022 | Sep. 16, 2021 | Jul. 31, 2021
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Percentage of common stock filed a lawsuit | 5.00% |  |  |  |
Legal and Other Expenses |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Litigation amount |  | $ 400,000 |  |  |
Contingent Value Rights Agreement |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Percentage of excess cash on dispositions net |  |  | 100.00% |  |
Excess amount retained from net proceeds related to disposition of assets |  |  | $ 1,000,000.0 |  |
Percentage of excess preapproved costs |  |  | 100.00% |  |
Vertex Asset Purchase Agreement | Contingent Value Rights Agreement |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Percentage of amount received on agreement |  |  | 100.00% |  |
F351 | G N I | Business Combination Agreement |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Termination fee required to pay upon termination of agreement |  |  | $ 2,000,000.0 |  |
F351 | G N I | Maximum | Business Combination Agreement |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Common stock, shares issued |  |  | 1,110,776,224 |  |
Reimbursement for out-of-pocket fees and expenses |  |  | $ 2,000,000.0 |  |
Dalcinonacog Alfa | Service Agreements |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Remaining obligations |  |  | 0 |  |
Clinical trial services cost incurred on agreement termination |  |  | 800,000 |  |
Dalcinonacog Alfa | Maximum | Service Agreements |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Cost of services as per agreement |  |  |  |  | $ 6,500,000
Catalent Indiana, LLC. | Dalcinonacog alfa. |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Remaining obligations |  |  | $ 0 |  |
Firm work order supporting clinical trials |  |  |  | $ 300,000 |

X
- Definition Clinical trial services cost incurred on agreement termination. + References No definition available. + Details
Name: | cbio_ClinicalTrialServicesCostIncurredOnAgreementTermination
Namespace Prefix: | cbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Commitments and contingencies disclosure. + References No definition available. + Details
Name: | cbio_CommitmentsAndContingenciesDisclosureLineItems
Namespace Prefix: | cbio_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cost of services as per agreement. + References No definition available. + Details
Name: | cbio_CostOfServicesAsPerAgreement
Namespace Prefix: | cbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Excess amount retained from net proceeds related to disposition of assets. + References No definition available. + Details
Name: | cbio_ExcessAmountRetainedFromNetProceedsRelatedToDispositionOfAssets
Namespace Prefix: | cbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Firm work order supporting clinical trials. + References No definition available. + Details
Name: | cbio_FirmWorkOrderSupportingClinicalTrials
Namespace Prefix: | cbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | instant

X
- Definition Litigation amount . + References No definition available. + Details
Name: | cbio_LitigationAmount
Namespace Prefix: | cbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Percentage of amount received on agreement. + References No definition available. + Details
Name: | cbio_PercentageOfAmountReceivedOnAgreement
Namespace Prefix: | cbio_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of common stock filed a lawsuit. + References No definition available. + Details
Name: | cbio_PercentageOfCommonStockFiledLawsuit
Namespace Prefix: | cbio_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of excess cash on dispositions net. + References No definition available. + Details
Name: | cbio_PercentageOfExcessCashOnDispositionsNet
Namespace Prefix: | cbio_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of excess preapproved costs. + References No definition available. + Details
Name: | cbio_PercentageOfExcessPreapprovedCosts
Namespace Prefix: | cbio_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Reimbursement for out-of-pocket fees and expenses. + References No definition available. + Details
Name: | cbio_ReimbursementForOutOfPocketFeesAndExpenses
Namespace Prefix: | cbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Termination fee required to pay upon termination of agreement. + References No definition available. + Details
Name: | cbio_TerminationFeeRequiredToPayUponTerminationOfAgreement
Namespace Prefix: | cbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of shares of equity interests issued or issuable to acquire entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(4) -URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments. + References No definition available. + Details
Name: | us-gaap_ContractualObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=cbio_LegalAndOtherExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cbio_ContingentValueRightsAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=cbio_VertexAssetPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cbio_FThreeFiveOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=cbio_GNIMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=cbio_BusinessCombinationAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cbio_DalcinonacogAlfaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cbio_IntegrityBioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=cbio_GMPMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |